In 584 patients with resected nonmetastatic colorectal cancer, ctDNA methylation-guided surveillance vs CT-based monitoring raised curative-intent treatment among those who recurred (48.1% vs 23.6%; RR 2.03); recurrence rates were similar (18.0% vs 18.6%).
RCTn = 584
Mo et al. Dynamic Circulating Tumor DNA Methylation Monitoring Guiding Postoperative Surveillance in Nonmetastatic Colorectal Cancer: A Prospective, Randomized, Phase III FIND Trial